Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment (Q37364125)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment |
scientific article |
Statements
1 reference
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment (English)
1 reference
Kenneth C S Fong
1 reference
Nigel Kirkpatrick
1 reference
Quresh Mohamed
1 reference
Robert L Johnston
1 reference
1 November 2008
1 reference
1 reference
Identifiers
1 reference